Table 2. AML subtypes, tumor markers and cytogenetic abnormalities.
Variables | N = 183 |
---|---|
FAB subtypes | |
M0 (%) | 42.6 |
M1 (%) | 6.6 |
M2 (%) | 16.9 |
M3 (%) | 15.3 |
M4 (%) | 8.7 |
M5 (%) | 8.7 |
M6 (%) | 0 |
M7 (%) | 1.1 |
Tumor markers | |
CD34 (%) | 54.1 |
Cytogenetic abnormalities | |
CALGB adverse profile (%) | 28.4 |
CALGB intermediate profile (%) | 56.8 |
CALGB favorable profile (%) | 14.8 |
Gene mutations | |
NPM1 (%) | 6 |
FLT3 (%) | 6.6 |